Second Annual AI & Drug Discovery Symposium

Goodwin hosts this Boston symposium on the opportunities and constraints shaping AI-enabled drug discovery. The program brings together life-sciences, technology and investment leaders to examine market dynamics, new collaboration models, regulatory and policy questions, data and intellectual-property strategy, and AI governance and security.

A networking reception follows the discussions. The official event page lists Goodwin's Boston office at 100 Northern Avenue and gives a 1pm to 6:30pm program. Register through the host's official event page.